1. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.
- Author
-
Rieckmann P and Mäurer M
- Subjects
- Animals, Axons drug effects, Axons pathology, Central Nervous System drug effects, Central Nervous System physiopathology, Humans, Immune System drug effects, Immune System immunology, Inflammation immunology, Inflammation physiopathology, Multiple Sclerosis immunology, Multiple Sclerosis physiopathology, Neuroprotective Agents therapeutic use, Wallerian Degeneration immunology, Wallerian Degeneration physiopathology, Anti-Inflammatory Agents therapeutic use, Axons immunology, Central Nervous System immunology, Inflammation therapy, Multiple Sclerosis therapy, Wallerian Degeneration therapy
- Abstract
Axonal injury in multiple sclerosis has attracted considerable interest during the past few years. It has been demonstrated in association with inflammation within active lesions, but it is also present in normal-appearing white matter. Because axonal loss appears to be responsible for persistent neurological deficits in patients with multiple sclerosis, treatment strategies to prevent damage to neurites and restore function are of paramount importance in controlling the disease process. Some of the currently available immunomodulatory therapies may also reduce axonal damage, as demonstrated using improved imaging technologies, but the precise mechanisms that could protect axons during the inflammatory attack are yet to be identified. Factors that are involved in functional impairment of axonal conduction and those elements that are responsible for direct structural damage to the axon are both potential targets for therapeutic interventions.
- Published
- 2002
- Full Text
- View/download PDF